Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Non-alcoholic fatty liver disease (NAFLD) is considered the most common cause of chronic liver disease in the world with an estimated prevalence of 20-30% in the United States and other Western populations. NAFLD is a slowly progressive disease and encompasses a spectrum of varying liver histology, ranging from simple steatosis to hepatocyte necro-apoptosis, and non-alcoholic steatohepatitis (NASH) which leads to variable grades of fibrosis and ultimately cirrhosis with its complications including hepatocellular carcinoma (HCC)